So, I emailed Nadar yesterday regarding the enroll
Post# of 145829
![](/assets/46931549/no_avatar_available_thumb.jpg)
I have to imagine it is one of the following (please chime in if you see other explanations):
1) He mispoke and enrollment is higher
2) He was actually referring to the enrollment in the Severe trial and meant to say 45 screened, 32 dosed.
3) Enrollment was stopped for some reason. Perhaps FDA is reviewing interim data and they are confident in the outcome? Seems like a stretch, but possible I suppose.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)